Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...
Vous n'êtes pas connecté
One of the biggest obstacles in cancer treatment is drug resistance in cancer cells. Conventional efforts have focused on identifying new drug targets to eliminate these resistant cells, but such approaches can often lead to even stronger resistance.
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...
Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...
Scientists at the University of Michigan Rogel Cancer Center have found an important clue to why some men with advanced prostate cancer don’t...
Van Andel Institute scientists have developed an improved technique to comprehensively profile DNA methylation in single cells, an advance that will...
Tiny lab-grown hearts are helping scientists crack the code of childhood heart disease and fast-track new treatments. Developed by scientists at QIMR...
Tiny lab-grown hearts are helping scientists crack the code of childhood heart disease and fast-track new treatments. Developed by scientists at QIMR...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jul. 14, 2025-- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jul. 14, 2025-- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the...
A promising new study from the Knight Family DIAN-TU research group at Washington University School of Medicine has found that starting Alzheimer’s...